News | Ultrasound Women's Health | January 13, 2017

Sofia 3-D Breast Ultrasound Receives Innovative Technology Designation from Vizient

Designation recognizes products that bring improvements to the healthcare industry

Hitachi Aloka, Sofia 3-D Breast Ultrasound, Innovative Technology Designation, Vizient Inc., RSNA 2016

January 13, 2017 — Hitachi Aloka Medical America Inc. announced in November that the Sofia 3-D Breast Ultrasound system received an Innovative Technology designation from Vizient Inc., the largest member-driven healthcare performance improvement company in the country. The designation was based on reviews of Sofia by hospital experts who attended Vizient’s Innovative Technology Exchange in September 2016. The event provided medical technology suppliers the opportunity to demonstrate their product and gain direct feedback from 1,300 onsite clinical experts and healthcare providers on the impact their products may have on improving clinical care and safety, or benefits to an organization’s care and business model.

Designed for women whose breast density may result in an inconclusive mammogram, Sofia uses ultrasound to create a 3-D volume of the whole breast. Patients are imaged in the prone position, placing their breast onto Sofia’s radial scanning array.  With the breast compressed simply by laying prone, the patient rests comfortably during the system’s rapid automated 30-second scan. The acquired high-resolution ultrasound images are then sent to the Sofia workstation and reconstructed into a 3-D volume of the entire breast that can be quickly interpreted by the radiologist.

“Due to the number of products and services being released and marketed as ‘innovative’, member hospitals truly value the peer-review system in place at Vizient to help them identify products worth further evaluation at their own facilities,” said Debbie Archer, director of procurement and leader of Vizient’s Innovative Technology program for suppliers.  “After a review of Sofia 3-D Breast Ultrasound system, Vizient’s members agreed this solution offers unique and incremental benefit over other products available on the market today, and recommended it for an Innovative Technology designation.”

For more information: www.hitachi-aloka.com

Related Content

Mammography, which is an X-ray picture of the breast, is efficient also for women over the age of 70.

Getty Images

News | Mammography | October 22, 2020
October 22, 2020 — ...
Rebrand reflects Volpara Health's mission to prevent advanced-stage breast cancer
News | Breast Imaging | October 19, 2020
October 19, 2020 — Volpara Solutions, a leader in AI-powered breast density assessment, announced that it has changed
More than 600,000 women die of advanced breast cancer annually. (1) There is a safe, universally obtainable method to reduce this terrible toll according to MammaCare Foundation scientist Mark Kane Goldstein, Ph.D.

Module 1

News | Women's Health | October 15, 2020
October 15, 2020 — More than 600,000 women die of advanced breast cancer annually. ...
Released in the lead up to #DenseBreastDay (30 September) and Breast Cancer Awareness Month (October), the animation explains how breast density can complicate mammogram screening and make it harder for medical professionals to detect breast cancer. This highly engaging animation shows a polar bear hiding in a snow globe as an analogy for cancer hiding in dense breast tissue. 

Image provided by Dilon

News | Breast Density | October 07, 2020
October 7, 2020 — A group of Australia’s leading breast can...
Microscopic photo of a professionally prepared slide demonstrating breast tissue with ductal carcinoma in situ (DCIS). Immuhistochemistry of estrogen receptor positive. Micrograph of breast cancer. Slide shows corresponding length of 1 mm.

Microscopic photo of a professionally prepared slide demonstrating breast tissue with ductal carcinoma in situ (DCIS). Immuhistochemistry of estrogen receptor positive. Micrograph of breast cancer. Slide shows corresponding length of 1 mm. Getty Images

News | Breast Imaging | October 05, 2020
October 5, 2020 — A major study of women with ductal carcinoma in situ (...
ASTRO urges radiation oncology benefits management company eviCore to reconsider a move that requires shorter treatment regimens without regard for physician judgement

Getty Images

News | Radiation Oncology | October 02, 2020
October 2, 2020 — Radiation oncologists expressed serious concerns about a new private insurance coverage policy that